IBDEI05B ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7057,1,5,0)
 ;;=5^Conversion Disorder
 ;;^UTILITY(U,$J,358.3,7057,2)
 ;;=^28139
 ;;^UTILITY(U,$J,358.3,7058,0)
 ;;=300.7^^45^483^2
 ;;^UTILITY(U,$J,358.3,7058,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7058,1,2,0)
 ;;=2^300.7
 ;;^UTILITY(U,$J,358.3,7058,1,5,0)
 ;;=5^Hyponchondriasis
 ;;^UTILITY(U,$J,358.3,7058,2)
 ;;=^60556
 ;;^UTILITY(U,$J,358.3,7059,0)
 ;;=300.81^^45^483^3
 ;;^UTILITY(U,$J,358.3,7059,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7059,1,2,0)
 ;;=2^300.81
 ;;^UTILITY(U,$J,358.3,7059,1,5,0)
 ;;=5^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,7059,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,7060,0)
 ;;=307.1^^45^484^1
 ;;^UTILITY(U,$J,358.3,7060,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7060,1,2,0)
 ;;=2^307.1
 ;;^UTILITY(U,$J,358.3,7060,1,5,0)
 ;;=5^Anorexia Nervosa
 ;;^UTILITY(U,$J,358.3,7060,2)
 ;;=^7942
 ;;^UTILITY(U,$J,358.3,7061,0)
 ;;=307.51^^45^484^2
 ;;^UTILITY(U,$J,358.3,7061,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7061,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,7061,1,5,0)
 ;;=5^Bulemia
 ;;^UTILITY(U,$J,358.3,7061,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,7062,0)
 ;;=307.50^^45^484^3
 ;;^UTILITY(U,$J,358.3,7062,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7062,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,7062,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,7062,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,7063,0)
 ;;=333.99^^45^485^1
 ;;^UTILITY(U,$J,358.3,7063,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7063,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,7063,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,7063,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,7064,0)
 ;;=332.0^^45^485^3
 ;;^UTILITY(U,$J,358.3,7064,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7064,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,7064,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,7064,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,7065,0)
 ;;=333.79^^45^485^2
 ;;^UTILITY(U,$J,358.3,7065,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7065,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,7065,1,5,0)
 ;;=5^Acute Dystonia
 ;;^UTILITY(U,$J,358.3,7065,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,7066,0)
 ;;=333.85^^45^485^4
 ;;^UTILITY(U,$J,358.3,7066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7066,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,7066,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,7066,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,7067,0)
 ;;=V87.39^^45^486^1
 ;;^UTILITY(U,$J,358.3,7067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7067,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,7067,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,7067,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,7068,0)
 ;;=310.0^^45^487^2
 ;;^UTILITY(U,$J,358.3,7068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7068,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,7068,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,7068,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,7069,0)
 ;;=310.1^^45^487^3
 ;;^UTILITY(U,$J,358.3,7069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7069,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,7069,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;^UTILITY(U,$J,358.3,7069,2)
 ;;=^331953
 ;;^UTILITY(U,$J,358.3,7070,0)
 ;;=310.2^^45^487^4
 ;;^UTILITY(U,$J,358.3,7070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7070,1,2,0)
 ;;=2^310.2
 ;;^UTILITY(U,$J,358.3,7070,1,5,0)
 ;;=5^Postconcussion Syndrome
 ;;^UTILITY(U,$J,358.3,7070,2)
 ;;=^265160
 ;;^UTILITY(U,$J,358.3,7071,0)
 ;;=310.81^^45^487^5
 ;;^UTILITY(U,$J,358.3,7071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7071,1,2,0)
 ;;=2^310.81
 ;;^UTILITY(U,$J,358.3,7071,1,5,0)
 ;;=5^Pseudobulbar Affect
 ;;^UTILITY(U,$J,358.3,7071,2)
 ;;=^340506
 ;;^UTILITY(U,$J,358.3,7072,0)
 ;;=310.89^^45^487^1
 ;;^UTILITY(U,$J,358.3,7072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7072,1,2,0)
 ;;=2^310.89
 ;;^UTILITY(U,$J,358.3,7072,1,5,0)
 ;;=5^Brain Damage D/O,Oth Spec
 ;;^UTILITY(U,$J,358.3,7072,2)
 ;;=^268320
 ;;^UTILITY(U,$J,358.3,7073,0)
 ;;=V79.0^^46^488^5
 ;;^UTILITY(U,$J,358.3,7073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7073,1,4,0)
 ;;=4^V79.0
 ;;^UTILITY(U,$J,358.3,7073,1,5,0)
 ;;=5^SCREENING FOR DEPRESSION
 ;;^UTILITY(U,$J,358.3,7073,2)
 ;;=^295677
 ;;^UTILITY(U,$J,358.3,7074,0)
 ;;=V79.1^^46^488^4
 ;;^UTILITY(U,$J,358.3,7074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7074,1,4,0)
 ;;=4^V79.1
 ;;^UTILITY(U,$J,358.3,7074,1,5,0)
 ;;=5^SCREENING FOR ALCOHOLISM
 ;;^UTILITY(U,$J,358.3,7074,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,7075,0)
 ;;=V79.2^^46^488^3
 ;;^UTILITY(U,$J,358.3,7075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7075,1,4,0)
 ;;=4^V79.2
 ;;^UTILITY(U,$J,358.3,7075,1,5,0)
 ;;=5^SCREEN-MENTAL RETARDAT
 ;;^UTILITY(U,$J,358.3,7075,2)
 ;;=^340656
 ;;^UTILITY(U,$J,358.3,7076,0)
 ;;=V79.3^^46^488^1
 ;;^UTILITY(U,$J,358.3,7076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7076,1,4,0)
 ;;=4^V79.3
 ;;^UTILITY(U,$J,358.3,7076,1,5,0)
 ;;=5^SCREEN-DEVELOPMENT PROB
 ;;^UTILITY(U,$J,358.3,7076,2)
 ;;=^295680
 ;;^UTILITY(U,$J,358.3,7077,0)
 ;;=V79.8^^46^488^2
 ;;^UTILITY(U,$J,358.3,7077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7077,1,4,0)
 ;;=4^V79.8
 ;;^UTILITY(U,$J,358.3,7077,1,5,0)
 ;;=5^SCREEN-MENTAL DIS NEC
 ;;^UTILITY(U,$J,358.3,7077,2)
 ;;=^295681
 ;;^UTILITY(U,$J,358.3,7078,0)
 ;;=V10.00^^46^489^9
 ;;^UTILITY(U,$J,358.3,7078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7078,1,4,0)
 ;;=4^V10.00
 ;;^UTILITY(U,$J,358.3,7078,1,5,0)
 ;;=5^HX OF GI MALIGNANCY NOS
 ;;^UTILITY(U,$J,358.3,7078,2)
 ;;=^295202
 ;;^UTILITY(U,$J,358.3,7079,0)
 ;;=V10.01^^46^489^21
 ;;^UTILITY(U,$J,358.3,7079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7079,1,4,0)
 ;;=4^V10.01
 ;;^UTILITY(U,$J,358.3,7079,1,5,0)
 ;;=5^HX OF TONGUE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7079,2)
 ;;=^295203
 ;;^UTILITY(U,$J,358.3,7080,0)
 ;;=V10.02^^46^489^38
 ;;^UTILITY(U,$J,358.3,7080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7080,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,7080,1,5,0)
 ;;=5^HX-ORAL/PHARYNX MALG NEC
 ;;^UTILITY(U,$J,358.3,7080,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,7081,0)
 ;;=V10.03^^46^489^25
 ;;^UTILITY(U,$J,358.3,7081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7081,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,7081,1,5,0)
 ;;=5^HX-ESOPHAGEAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7081,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,7082,0)
 ;;=V10.04^^46^489^7
 ;;^UTILITY(U,$J,358.3,7082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7082,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,7082,1,5,0)
 ;;=5^HX OF GASTRIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7082,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,7083,0)
 ;;=V10.05^^46^489^5
 ;;^UTILITY(U,$J,358.3,7083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7083,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,7083,1,5,0)
 ;;=5^HX OF COLONIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7083,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,7084,0)
 ;;=V10.06^^46^489^40
 ;;^UTILITY(U,$J,358.3,7084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7084,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,7084,1,5,0)
 ;;=5^HX-RECTAL ANAL MALIGN
 ;;^UTILITY(U,$J,358.3,7084,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,7085,0)
 ;;=V10.07^^46^489^13
 ;;^UTILITY(U,$J,358.3,7085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7085,1,4,0)
 ;;=4^V10.07
 ;;^UTILITY(U,$J,358.3,7085,1,5,0)
 ;;=5^HX OF LIVER MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7085,2)
 ;;=^295209
 ;;^UTILITY(U,$J,358.3,7086,0)
 ;;=V10.09^^46^489^8
 ;;^UTILITY(U,$J,358.3,7086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7086,1,4,0)
 ;;=4^V10.09
 ;;^UTILITY(U,$J,358.3,7086,1,5,0)
 ;;=5^HX OF GI MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,7086,2)
 ;;=^295210
 ;;^UTILITY(U,$J,358.3,7087,0)
 ;;=V10.11^^46^489^22
 ;;^UTILITY(U,$J,358.3,7087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7087,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,7087,1,5,0)
 ;;=5^HX-BRONCHOGENIC MALIGNAN
 ;;^UTILITY(U,$J,358.3,7087,2)
 ;;=^295211
 ;;^UTILITY(U,$J,358.3,7088,0)
 ;;=V10.12^^46^489^44
 ;;^UTILITY(U,$J,358.3,7088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7088,1,4,0)
 ;;=4^V10.12
 ;;^UTILITY(U,$J,358.3,7088,1,5,0)
 ;;=5^HX-TRACHEAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7088,2)
 ;;=^295212
 ;;^UTILITY(U,$J,358.3,7089,0)
 ;;=V10.20^^46^489^41
 ;;^UTILITY(U,$J,358.3,7089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7089,1,4,0)
 ;;=4^V10.20
 ;;^UTILITY(U,$J,358.3,7089,1,5,0)
 ;;=5^HX-RESP ORG MALIGNAN NOS
 ;;^UTILITY(U,$J,358.3,7089,2)
 ;;=^295213
 ;;^UTILITY(U,$J,358.3,7090,0)
 ;;=V10.21^^46^489^30
 ;;^UTILITY(U,$J,358.3,7090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7090,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,7090,1,5,0)
 ;;=5^HX-LARYNGEAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7090,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,7091,0)
 ;;=V10.22^^46^489^37
 ;;^UTILITY(U,$J,358.3,7091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7091,1,4,0)
 ;;=4^V10.22
 ;;^UTILITY(U,$J,358.3,7091,1,5,0)
 ;;=5^HX-NOSE/EAR/SINUS MALIG
 ;;^UTILITY(U,$J,358.3,7091,2)
 ;;=^295215
 ;;^UTILITY(U,$J,358.3,7092,0)
 ;;=V10.29^^46^489^29
 ;;^UTILITY(U,$J,358.3,7092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7092,1,4,0)
 ;;=4^V10.29
 ;;^UTILITY(U,$J,358.3,7092,1,5,0)
 ;;=5^HX-INTRATHORACIC MAL NEC
 ;;^UTILITY(U,$J,358.3,7092,2)
 ;;=^295216
 ;;^UTILITY(U,$J,358.3,7093,0)
 ;;=V10.3^^46^489^4
 ;;^UTILITY(U,$J,358.3,7093,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7093,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,7093,1,5,0)
 ;;=5^HX OF BREAST MALIGNANCY
 ;;^UTILITY(U,$J,358.3,7093,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,7094,0)
 ;;=V10.40^^46^489^27
 ;;^UTILITY(U,$J,358.3,7094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7094,1,4,0)
 ;;=4^V10.40
 ;;^UTILITY(U,$J,358.3,7094,1,5,0)
 ;;=5^HX-FEMALE GENIT MALG NOS
 ;;^UTILITY(U,$J,358.3,7094,2)
 ;;=^295218
 ;;^UTILITY(U,$J,358.3,7095,0)
 ;;=V10.41^^46^489^23
 ;;^UTILITY(U,$J,358.3,7095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7095,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,7095,1,5,0)
 ;;=5^HX-CERVICAL MALIGNANCY
